Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group

Semin Hematol. 1993 Jul;30(3 Suppl 3):44-8.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Busulfan / therapeutic use
  • Humans
  • Hydroxyurea / therapeutic use*
  • Interferon-alpha / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Prognosis
  • Survival Analysis

Substances

  • Interferon-alpha
  • Busulfan
  • Hydroxyurea